DiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026

Go back to DiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026
(NASDAQ: DMAC) Delayed: 7.04 -0.18 (2.49%)
Previous Close $7.22    52 Week High
Open $7.21    52 Week Low
Day High $7.45    P/E N/A 
Day Low $7.01    EPS
Volume 301,656